Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült Államok3. fázis

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

A legfontosabb adatok

Ki végzi
GlaxoSmithKline
Hol
Albany, Altamonte Springs, Anderson, Anniston, Atlanta, Aurora, Austin, Baltimore, Blue Ash, Boston, Brookline, Brownsville, Camp Hill, Carrollton, Charlotte, Charlottesville, Chesterfield, Chicago, Chickasha, Cincinnati, Colorado Springs, Columbus, Cypress, Dallas, Decatur, Denver, DeSoto, Dublin, Durham, Edinburg, El Paso, Elkhorn, Escondido, Fair Oaks, Fayetteville, Fort Lauderdale, Fort Worth, Friendswood, Garden City, Garland, Glendale, Grand Island, Greensboro, Gulfport, Guntersville, Hartsdale, Hialeah, Hickory, Homestead, Houston, Irving, Kansas City, Keller, Knoxville, La Palma, Lafayette, Lake Mary, Lake Worth, Laredo, Las Vegas, Lenexa, Lima, Little River, Little Rock, Maitland, Marietta, McKinney, Melbourne, Meridian, Mesa, Mesquite, Metairie, Miami, Miami Lakes, Morton, Myrtle Beach, New Orleans, Newport News, Norfolk, North Charleston, Oklahoma City, Omaha, Orlando, Palmetto Bay, Pearland, Peoria, Philadelphia, Phoenix, Plano, Port Orange, Portland, Raleigh, Redding, Renton, Richmond, Riverdale, Riverside, Rochester, Rolling Hills Estates, Salisbury, Salt Lake City, San Antonio, San Bernardino, San Diego, Santa Fe, Savannah, Scottsdale, Seattle, South Ogden, Southfield, Spartanburg, St Louis, Stamford, Stephenville, Sun City, Tamarac, Tampa, Tempe, The Villages, The Woodlands, Tucson, Tulsa, Valparaiso, Walnut Creek, Warren Township, Waterbury, West Jordan, West Palm Beach, Wilmington és Winston-Salem (Egyesült Államok)Mind a 130 helyszín megnézése
Állapot
Toboroz
Fázis
3. fázis
Résztvevők
54 000 fő, tervezett
Kezdés
2026. szept. 2.
Várható befejezés
2028. jún. 9.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • mRNA Seasonal Flu vaccine
  • Licensed Influenza Vaccine
A regiszteradat frissítve
2026. szeptember 18.

Ki vehet részt

Életkor
65 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 28 feltétel megnézéseKevesebb

Ki vehet részt

  • Participants who, in the opinion of the investigator, can and will comply with the requirements of the protocol independently or with the assistance of a caregiver
  • Written or witnessed (physically or digitally) informed consent obtained from the participant/Legally acceptable representative [LAR(s)] of the participant prior to performance of any study-specific procedure
  • Healthy participants or medically stable patients as established by medical history and clinical examination. Participants with chronic medical conditions with or without specific treatment are allowed to participate in this study if considered by the investigator as medically stable. A stable medical condition is defined as disease not requiring significant change in therapy or hospitalization for worsening disease during 3 months before enrollment
  • A male or female participant at least 65 YOA at the time of the study intervention administration

Ki nem vehet részt

  • History of test-confirmed influenza infection within 180 days prior to study intervention administration
  • History of hypersensitivity or allergic reaction to any previous influenza vaccine
  • History of hypersensitivity or allergic reaction to any previous mRNA vaccine
  • History of Guillain-Barré syndrome (GBS) within 6 weeks of receiving any vaccine
  • Administration of an influenza vaccine in the period starting 180 days before the study intervention administration or planned administration at any time during the study
  • Planned administration/administration of any mRNA-based vaccine, live vaccine or adjuvanted protein-based vaccine in the period starting 30 days before the study intervention administration (Day -29 to Day 1) and ending 28 days after the study intervention administration (Day 1 to Day 28) or a non-replicating vaccine in the period starting 15 days before the study intervention administration (Day -14 to Day 1) and ending 14 days after the study intervention administration (Day 1 to Day 14)
  • Use of any investigational or non-registered product (drug, vaccine or invasive medical device in the country of enrollment) other than the study intervention during the period beginning 30 days before the dose of study intervention (Day -29 to Day 1), or their planned use during the study period
  • Administration of immunoglobulins or other blood products or plasma derivatives during the period starting 90 days before the study intervention (Day -89 to Day 1) or planned administration during the study period
  • Chronic administration of immune-modifying drugs (defined as more than 14 consecutive days in total) and/or planned use of long-acting immune-modifying treatments at any time up to the end of the study; Up to 90 days prior to the study intervention administration:; For systemic corticosteroids: prednisone equivalent ≥20 mg/day for >14 days. Inhaled, intra articular/intra-bursal, and topical steroids are allowed; Long-acting immune-modifying drugs including among others immunotherapy (e.g., TNF-inhibitors), monoclonal antibodies, antitumoral medication
  • Administration of antitumoral medication during the period starting 90 days before the study intervention (Day -89 to Day 1) or planned administration during the study period
  • Administration of any vaccine in a clinical trial investigating an influenza mRNA vaccine in the period starting 1 year before the study intervention administration
  • Concurrently participating in another clinical study at any time during the study period, in which the participant has been or will be exposed to an investigational or a non-investigational intervention (drug/invasive medical device)
  • For enrollment in Season 2: Previous participation (i.e., during previous season) in this clinical study
  • Hypersensitivity to latex
  • History of myocarditis or pericarditis considered causally associated with mRNA vaccine
  • History of any reaction or hypersensitivity likely to be exacerbated by any component of the study intervention(s)
  • Significant underlying illness that in the opinion of the investigator would be expected to prevent completion of the study
  • Acute or unstable chronic conditions [clinically significant pulmonary, cardiovascular, hepatic, metabolic/endocrine disorders, renal functional abnormality, or psychiatric conditions], as determined by medical history and clinical examination
  • Any other clinical condition that, in the opinion of the investigator, might pose additional risk to the participant, due to participation in the clinical study
  • Condition that in the judgment of the investigator would make intramuscular injection unsafe
  • Any confirmed or suspected immunosuppressive or immunodeficient condition. HIV-infected individuals may be enrolled if they have been stable on antiretroviral therapy for the past 6 consecutive months, their CD4 cell count is ≥ 200/mm³ and their viral load has been undetectable
  • Planned move during the study period that will prohibit participating in the study until study end
  • Planned leave or holiday of 4 consecutive weeks or more during the influenza season covered by the study, that would prohibit the reporting of ILI cases and attendance to ILI visit
  • Any study personnel or their immediate dependents, family, or household members

Helyszínek itt: Egyesült Államok

  • Albany, New YorkHospital not named in the registryContact: Charles Kemp (principal investigator)Résztvevőt keres
  • Altamonte Springs, FloridaHospital not named in the registryContact: Andrew Feldman (principal investigator)Résztvevőt keres
  • Anderson, South CarolinaHospital not named in the registryContact: Daniel Williams (principal investigator)Résztvevőt keres
  • Anniston, AlabamaHospital not named in the registryContact: Almena Free (principal investigator)Résztvevőt keres
  • Atlanta, GeorgiaHospital not named in the registryContact: Jason Agran (principal investigator)Résztvevőt keres
  • Aurora, ColoradoHospital not named in the registryContact: Timothy Colander (principal investigator)Résztvevőt keres
  • Austin, TexasHospital not named in the registryContact: Timothy Vachris (principal investigator)Résztvevőt keres
  • Baltimore, MarylandHospital not named in the registryContact: Dima Hnoosh (principal investigator)Résztvevőt keres
  • Blue Ash, OhioHospital not named in the registryContact: Audrius Ruksenas (principal investigator)Résztvevőt keres
  • Boston, MassachusettsHospital not named in the registryContact: Antonio Mendes (principal investigator)Résztvevőt keres
  • Brookline, MassachusettsHospital not named in the registryContact: James Katz (principal investigator)Résztvevőt keres
  • Brownsville, TexasHospital not named in the registryContact: Christopher Romero (principal investigator)Résztvevőt keres
  • Camp Hill, PennsylvaniaHospital not named in the registryContact: Venkatesh Nadar (principal investigator)Résztvevőt keres
  • Carrollton, TexasHospital not named in the registryContact: Andrea Brown (principal investigator)Résztvevőt keres
  • Charlotte, North CarolinaHospital not named in the registryContact: Christina Kennelly (principal investigator)Résztvevőt keres
  • Charlottesville, VirginiaHospital not named in the registryContact: James Clark (principal investigator)Résztvevőt keres
  • Chesterfield, MissouriHospital not named in the registryContact: Timothy Jennings (principal investigator)Résztvevőt keres
  • Chicago, IllinoisHospital not named in the registryContact: Dennis Levinson (principal investigator)Résztvevőt keres
  • Chickasha, OklahomaHospital not named in the registryContact: Ahmad Musa (principal investigator)Résztvevőt keres
  • Cincinnati, OhioHospital not named in the registryContact: Charles Eger (principal investigator)Résztvevőt keres
  • Colorado Springs, ColoradoHospital not named in the registryContact: Charles Bird (principal investigator)Résztvevőt keres
  • Columbus, OhioHospital not named in the registryContact: Sridhar Guduri (principal investigator)Résztvevőt keres
  • Cypress, TexasHospital not named in the registryContact: Dileep Puppala (principal investigator)Résztvevőt keres
  • Dallas, TexasHospital not named in the registryContact: Bachar Elsaadi (principal investigator)Résztvevőt keres
  • Decatur, GeorgiaHospital not named in the registryContact: Ramana Puppala (principal investigator)Résztvevőt keres
  • Denver, ColoradoHospital not named in the registryContact: Robert Williams (principal investigator)Résztvevőt keres
  • DeSoto, TexasHospital not named in the registryContact: Haresh Boghara (principal investigator)Résztvevőt keres
  • Dublin, OhioHospital not named in the registryContact: Alfred Tan (principal investigator)Résztvevőt keres
  • Durham, North CarolinaHospital not named in the registryContact: Sherif Naguib (principal investigator)Résztvevőt keres
  • Edinburg, TexasHospital not named in the registryContact: German Esquivel (principal investigator)Résztvevőt keres
  • El Paso, TexasHospital not named in the registryContact: Jose Burgos (principal investigator)Résztvevőt keres
  • Elkhorn, NebraskaHospital not named in the registryContact: William Fitzgibbons (principal investigator)Résztvevőt keres
  • Escondido, CaliforniaHospital not named in the registryContact: Vicki Miller (principal investigator)Résztvevőt keres
  • Fair Oaks, CaliforniaHospital not named in the registryContact: Masaru Oshita (principal investigator)Résztvevőt keres
  • Fayetteville, ArkansasHospital not named in the registryContact: Charlotte Mathis (principal investigator)Résztvevőt keres
  • Fort Lauderdale, FloridaHospital not named in the registryContact: David Mishkin (principal investigator)Résztvevőt keres
  • Fort Worth, TexasHospital not named in the registryContact: William Seger (principal investigator)Résztvevőt keres
  • Friendswood, TexasHospital not named in the registryContact: Efrain Soto (principal investigator)Résztvevőt keres
  • Garden City, MichiganHospital not named in the registryContact: Renee Dwaihy (principal investigator)Résztvevőt keres
  • Garland, TexasHospital not named in the registryContact: Laquita Shepherd (principal investigator)Résztvevőt keres
  • Glendale, WisconsinHospital not named in the registryContact: Abram Burgher (principal investigator)Résztvevőt keres
  • Grand Island, NebraskaHospital not named in the registryContact: Adam Brosz (principal investigator)Résztvevőt keres
  • Greensboro, North CarolinaHospital not named in the registryContact: Alexander Murray (principal investigator)Résztvevőt keres
  • Gulfport, MississippiHospital not named in the registryContact: Sean Kerby (principal investigator)Résztvevőt keres
  • Guntersville, AlabamaHospital not named in the registryContact: William A Nixon (principal investigator)Résztvevőt keres
  • Hartsdale, New YorkHospital not named in the registryContact: Michael Gerdis (principal investigator)Résztvevőt keres
  • Hialeah, FloridaHospital not named in the registryContact: Wilson Cueva (principal investigator)Résztvevőt keres
  • Hickory, North CarolinaHospital not named in the registryContact: Scott Polster (principal investigator)Résztvevőt keres
  • Homestead, FloridaHospital not named in the registryContact: Julio Valdes-Liste (principal investigator)Résztvevőt keres
  • Houston, TexasHospital not named in the registryContact: Jose Melendez (principal investigator)Résztvevőt keres
  • Irving, TexasHospital not named in the registryContact: Danielle Coulter (principal investigator)Résztvevőt keres
  • Kansas City, MissouriHospital not named in the registryContact: Srinivas Nalamachu (principal investigator)Résztvevőt keres
  • Keller, TexasHospital not named in the registryContact: Gregory Fuller (principal investigator)Résztvevőt keres
  • Knoxville, TennesseeHospital not named in the registryContact: Amanda Miller (principal investigator)Résztvevőt keres
  • La Palma, CaliforniaHospital not named in the registryContact: Andrew Morado (principal investigator)Résztvevőt keres
  • Lafayette, ColoradoHospital not named in the registryContact: Jibran Atwi (principal investigator)Résztvevőt keres
  • Lake Mary, FloridaHospital not named in the registryContact: Bruce Rankin (principal investigator)Résztvevőt keres
  • Lake Worth, FloridaHospital not named in the registryContact: David Halpert (principal investigator)Résztvevőt keres
  • Laredo, TexasHospital not named in the registryContact: Jose Garcia (principal investigator)Résztvevőt keres
  • Las Vegas, NevadaHospital not named in the registryContact: Stephen Tam (principal investigator)Résztvevőt keres
  • Lenexa, KansasHospital not named in the registryContact: Carlos Fierro (principal investigator)Résztvevőt keres
  • Lima, OhioHospital not named in the registryContact: Nonso Ezema (principal investigator)Résztvevőt keres
  • Little River, South CarolinaHospital not named in the registryContact: Stephen Grubb (principal investigator)Résztvevőt keres
  • Little Rock, ArkansasHospital not named in the registryContact: Derek Lewis (principal investigator)Résztvevőt keres
  • Maitland, FloridaHospital not named in the registryContact: Theodore Lee (principal investigator)Résztvevőt keres
  • Marietta, GeorgiaHospital not named in the registryContact: Marvin Tark (principal investigator)Résztvevőt keres
  • McKinney, TexasHospital not named in the registryContact: Asad Karim (principal investigator)Résztvevőt keres
  • Melbourne, FloridaHospital not named in the registryContact: Murray Kimmel (principal investigator)Résztvevőt keres
  • Meridian, IdahoHospital not named in the registryContact: Mark Turner (principal investigator)Résztvevőt keres
  • Mesa, ArizonaHospital not named in the registryContact: Tami Bruce (principal investigator)Résztvevőt keres
  • Mesquite, TexasHospital not named in the registryContact: Salma Saiger (principal investigator)Résztvevőt keres
  • Metairie, LouisianaHospital not named in the registryContact: David Dulitz (principal investigator)Résztvevőt keres
  • Miami, FloridaHospital not named in the registryContact: Pedro San Martin Parra (principal investigator)Résztvevőt keres
  • Miami Lakes, FloridaHospital not named in the registryContact: Sheila Sanchez (principal investigator)Résztvevőt keres
  • Morton, IllinoisHospital not named in the registryContact: Stanley Koch (principal investigator)Résztvevőt keres
  • Myrtle Beach, South CarolinaHospital not named in the registryContact: Donald Eagerton (principal investigator)Résztvevőt keres
  • New Orleans, LouisianaHospital not named in the registryContact: Patrick Dennis (principal investigator)Résztvevőt keres
  • Newport News, VirginiaHospital not named in the registryContact: George Freeman (principal investigator)Résztvevőt keres
  • Norfolk, VirginiaHospital not named in the registryContact: Charles Harper (principal investigator)Résztvevőt keres
  • North Charleston, South CarolinaHospital not named in the registryContact: Rica Santiago (principal investigator)Résztvevőt keres
  • Oklahoma City, OklahomaHospital not named in the registryContact: Carl Griffin (principal investigator)Résztvevőt keres
  • Omaha, NebraskaHospital not named in the registryContact: Brian Hollis (principal investigator)Résztvevőt keres
  • Orlando, FloridaHospital not named in the registryContact: Edgardo Rivera (principal investigator)Résztvevőt keres
  • Palmetto Bay, FloridaHospital not named in the registryContact: Karen Figueredo Reyes (principal investigator)Résztvevőt keres
  • Pearland, TexasHospital not named in the registryContact: Murtaza Mussaji (principal investigator)Résztvevőt keres
  • Peoria, IllinoisHospital not named in the registryContact: Daniel Brune (principal investigator)Résztvevőt keres
  • Philadelphia, PennsylvaniaHospital not named in the registryContact: David Wheeler (principal investigator)Résztvevőt keres
  • Phoenix, ArizonaHospital not named in the registryContact: Brock Merritt (principal investigator)Résztvevőt keres
  • Plano, TexasHospital not named in the registryContact: Michele Reynolds (principal investigator)Résztvevőt keres
  • Port Orange, FloridaHospital not named in the registryContact: Bhanu Visvalingam (principal investigator)Résztvevőt keres
  • Portland, MaineHospital not named in the registryContact: Andre Barkhuizen (principal investigator)Résztvevőt keres
  • Raleigh, North CarolinaHospital not named in the registryContact: Matthew Hong (principal investigator)Résztvevőt keres
  • Redding, CaliforniaHospital not named in the registryContact: Rafael Lupercio (principal investigator)Résztvevőt keres
  • Renton, WashingtonHospital not named in the registryContact: Sheryl Marks (principal investigator)Résztvevőt keres
  • Richmond, VirginiaHospital not named in the registryContact: Leroy Vaughan (principal investigator)Résztvevőt keres
  • Riverdale, CaliforniaHospital not named in the registryContact: Deon Miller (principal investigator)Résztvevőt keres
  • Riverside, CaliforniaHospital not named in the registryContact: Jack Vu (principal investigator)Résztvevőt keres
  • Rochester, MinnesotaHospital not named in the registryContact: Patrick Connors (principal investigator)Résztvevőt keres
  • Rolling Hills Estates, CaliforniaHospital not named in the registryContact: Lawrence Sher (principal investigator)Résztvevőt keres
  • Salisbury, North CarolinaHospital not named in the registryContact: Kishan Maramraj (principal investigator)Résztvevőt keres
  • Salt Lake City, UtahHospital not named in the registryContact: Todd Bertoch (principal investigator)Résztvevőt keres
  • San Antonio, TexasHospital not named in the registryContact: Rashid Atique (principal investigator)Résztvevőt keres
  • San Bernardino, CaliforniaHospital not named in the registryContact: Judith Kirstein (principal investigator)Résztvevőt keres
  • San Diego, CaliforniaHospital not named in the registryContact: Stacey Layle (principal investigator)Résztvevőt keres
  • Santa Fe, New MexicoHospital not named in the registryContact: Wendy Johnson (principal investigator)Résztvevőt keres
  • Savannah, GeorgiaHospital not named in the registryContact: Thomas Moriarity (principal investigator)Résztvevőt keres
  • Scottsdale, ArizonaHospital not named in the registryContact: Ben Clark (principal investigator)Résztvevőt keres
  • Seattle, WashingtonHospital not named in the registryContact: Rebecca Dunsmoor-Su (principal investigator)Résztvevőt keres
  • South Ogden, UtahHospital not named in the registryContact: John Hemmersmeier (principal investigator)Résztvevőt keres
  • Southfield, MichiganHospital not named in the registryContact: Diana Carlson (principal investigator)Résztvevőt keres
  • Spartanburg, South CarolinaHospital not named in the registryContact: Christopher Davis (principal investigator)Résztvevőt keres
  • St Louis, MissouriHospital not named in the registryContact: Jeffrey Tillinghast (principal investigator)Résztvevőt keres
  • Stamford, ConnecticutHospital not named in the registryContact: David Radin (principal investigator)Résztvevőt keres
  • Stephenville, TexasHospital not named in the registryContact: Benjamin Marcum (principal investigator)Résztvevőt keres
  • Sun City, ArizonaHospital not named in the registryContact: Rachel Greatwood (principal investigator)Résztvevőt keres
  • Tamarac, FloridaHospital not named in the registryContact: Mazyar Rouhani (principal investigator)Résztvevőt keres
  • Tampa, FloridaHospital not named in the registryContact: Al Robaina (principal investigator)Résztvevőt keres
  • Tempe, ArizonaHospital not named in the registryContact: Thomas Fiel (principal investigator)Résztvevőt keres
  • The Villages, FloridaHospital not named in the registryContact: Angela Okolie (principal investigator)Résztvevőt keres
  • The Woodlands, TexasHospital not named in the registryContact: Clifford Yut (principal investigator)Résztvevőt keres
  • Tucson, ArizonaHospital not named in the registryContact: Anita Kohli (principal investigator)Résztvevőt keres
  • Tulsa, OklahomaHospital not named in the registryContact: Melita Tate (principal investigator)Résztvevőt keres
  • Valparaiso, IndianaHospital not named in the registryContact: Robert Buynak (principal investigator)Résztvevőt keres
  • Walnut Creek, CaliforniaHospital not named in the registryContact: Helen Stacey (principal investigator)Résztvevőt keres
  • Warren Township, New JerseyHospital not named in the registryContact: Samar Hameed (principal investigator)Résztvevőt keres
  • Waterbury, ConnecticutHospital not named in the registryContact: Joseph Soufer (principal investigator)Résztvevőt keres
  • West Jordan, UtahHospital not named in the registryContact: Barbara Rizzardi (principal investigator)Résztvevőt keres
  • West Palm Beach, FloridaHospital not named in the registryContact: Mira Baron (principal investigator)Résztvevőt keres
  • Wilmington, North CarolinaHospital not named in the registryContact: Barton Williams (principal investigator)Résztvevőt keres
  • Winston-Salem, North CarolinaHospital not named in the registryContact: Jonathan Wilson (principal investigator)Résztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

This study will compare an investigational mRNA flu vaccine with a licensed flu vaccine in adults 65 years of age and older. Participants will receive one injection and will be followed during the flu season. The study will measure prevention of laboratory-confirmed flu illness, side effects, and immune responses.

A vizsgálat 2 csoportja

  • mRNA Seasonal Flu VaccineA vizsgált kezelés

    Participants will receive a single dose of investigational mRNA Seasonal Flu vaccine on Day 1.

  • Active ComparatorMár használt kezelés, összehasonlításként

    Participants will receive a single dose of an age-appropriate and season-adapted licensed influenza vaccine Day 1.

    Kezelés: Licensed Influenza Vaccine

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Phase 3 Randomized, Observer-Blind, Controlled Study to Evaluate the Clinical Efficacy of an mRNA Based Seasonal Influenza Vaccine in Older Adults ≥65 Years of Age
A regiszteradat frissítve
2026. szeptember 18.